RFK Jr. Signals FDA May Let Pharmacies Compound About 14 Synthetic Peptides Despite Limited Human Safety Data
7d
Developing
2
Robert F. Kennedy Jr. told Joe Rogan he expects the FDA to reclassify “about 14” synthetic peptides within weeks so compounding pharmacies could legally make them — examples cited include BPC‑157, ipamorelin and MOTS‑C — though HHS declined to give a firm timeline, saying the agency’s aim is to ensure appropriate quality standards. Experts warn the peptides would still be unapproved drugs with little rigorous human safety or efficacy data (mostly animal, cell studies and a few small trials), and clinicians report a booming black‑ and gray‑market that raises contamination and mislabeling risks.